OPSYON Therapeutics
PrivateLast Round
Grant
Apr 1, 2022
Company Overview
OPSYON Therapeutics is a biotechnology company that is a preclinical stage biopharmaceutical company focused on the development of first-in-class therapeutics for immunological and oncological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OPSYON Therapeutics Comparables
Compare OPSYON Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sairopa B.V. | 81% | |
| HanchorBio, Inc. | 78% | |
| Molecular Partners AG | 76% | |
OPSYON Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2022 |
OPSYON Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Ministry for Economic Affairs and Energy | Grant |
OPSYON Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OPSYON Therapeutics's valuation, stock price, and market status.